INTRODUCING SOTROVIMAB: A NEW MONOCLONAL ANTIBODY THERAPY FOR THE EARLY TREATMENT OF COVID-19

Event Date: 29th September 2021

TIME: 19:00- 20:00 AEST

Title: Introducing sotrovimab - a new monoclonal antibody therapy for the early treatment of COVID-19

Webinar Agenda:

  • 7:00pm - 7:30pm Anti-SARS-CoV-2 monoclonal antibody therapy for the early treatment of COVID-19 in patients at increased risk of disease progression.
  • 7:30pm - 8:00pm - Q&A with COVID-19 Rapid Response Team GP; Triage, management and referral of COVID-19 patients in the community and hotel quarantine

Speakers:

  • Associate Professor Joe Sasadeusz

Associate Professor Joe Sasadeusz is an infectious diseases physicianwho subspecialises in medical virology and is the holder of multiple research grants including a current NHMRC research grant on the topic of Hepatitis cure. Associate Professor Sasadeusz consults at the Victorian Infectious Diseases Service at the Royal Melbourne Hospital and at The Alfred Hospital where he has extensive experience managing patients with COVID-19.

  • Dr. Jo Grey

Dr Jo Grey is a GP practicing at St Vincent’s Hospital. Her extensive career has been enhanced by post-graduate study in Public Health, Travel & Tropical Medicine and Infectious Diseases. Dr Grey’s most recent assignment is as part of the DHHS COVID-19 Rapid Response team in Melbourne.


Register Now by clicking HERE


For further information, please contact:
Erin O’Callaghan, PhD
Medical Science Liaison
Erin.x.o’callaghan@gsk.com
Mobile +61 436 474 822


GSK-convened education event


Registrations are closed